Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Equity Ratio (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Equity Ratio data on record, last reported at 0.17 in Q3 2025.

  • For Q3 2025, Equity Ratio rose 19.33% year-over-year to 0.17; the TTM value through Sep 2025 reached 0.17, up 19.33%, while the annual FY2024 figure was 0.14, 19.53% down from the prior year.
  • Equity Ratio reached 0.17 in Q3 2025 per COLL's latest filing, up from 0.15 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.35 in Q2 2021 and bottomed at 0.14 in Q4 2024.
  • Average Equity Ratio over 5 years is 0.19, with a median of 0.17 recorded in 2023.
  • Peak YoY movement for Equity Ratio: skyrocketed 47.24% in 2021, then plummeted 55.25% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.29 in 2021, then tumbled by 43.4% to 0.17 in 2022, then grew by 3.01% to 0.17 in 2023, then decreased by 19.53% to 0.14 in 2024, then increased by 24.29% to 0.17 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.17 in Q3 2025, 0.15 in Q2 2025, and 0.14 in Q1 2025.